## XYL: Xylem Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.9% below STRENGTH zone (3.0-6.0%); PEG 2.12 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($134.50)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Wall Street Zen Downgrades Xylem (NYSE:XYL) to Hold**
- Source: MarketBeat | 20251227T070854 | Neutral | Relevance: 100%
- Wall Street Zen downgraded Xylem (NYSE:XYL) from a "buy" to a "hold" rating, though the consensus remains a "Moderate Buy" with an average price target of $167.40. Xylem surpassed quarterly expectations with $1.37 EPS and $2.27 billion revenue, also setting strong FY2025 guidance. Despite insider share sales, institutional investors hold a significant 87.96% of the stock.

**2. Swedbank AB Has $766.67 Million Stock Holdings in Xylem Inc. $XYL**
- Source: MarketBeat | 20251224T135454 | Bullish | Relevance: 100%
- Swedbank AB significantly increased its stake in Xylem Inc. (NYSE:XYL) by 19% in the third quarter, now holding over 5.19 million shares valued at approximately $766.67 million, making it their 19th largest holding. Xylem reported strong Q3 earnings, surpassing analyst expectations with $1.37 EPS and $2.27 billion in revenue, and maintains a "Moderate Buy" consensus rating from analysts. The article also details recent insider transactions and analyst rating changes for Xylem.

**3. Market Participants Recognise Graham Corporation's (NYSE:GHM) Earnings Pushing Shares 29% Higher**
- Source: Simply Wall Street | 20251224T101334 | Neutral | Relevance: 62%
- Graham Corporation's shares have risen 29% in the last month and are up 58% over the past year, leading to a P/E ratio of 55.9x, significantly higher than the market average in the United States. This high P/E is supported by the company's strong recent earnings growth of 75% and an anticipated EPS increase of 24% in the coming year, surpassing the broader market forecast of 16%. The market appears to be confident in Graham's future growth prospects, justifying its elevated valuation.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | TD Cowen | $135 | $130 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | TD Cowen | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($2.22M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.7% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.3% (+0.7%)
- Blackrock Inc.: 10.2% (+1.6%)
- State Street Corpora: 4.5% (+1.2%)
- Geode Capital Manage: 2.5% (+1.1%)
- Impax Asset Manageme: 2.2% (-3.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.12 elevated, pricing in significant growth expectations. Forward P/E 25.0x stretched relative to 10% growth. Insider selling cluster ($2.2M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $33.8B |
| Beta | 1.17 |
| 52W Range | $100.47 - $154.27 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.12 |
| Forward P/E | 25.0 |
| Current P/E | 27.4 |
| YoY Growth | 9.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.9% over 5 days). Below STRENGTH zone by 3.9pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.04x) but short-term weakness (below SMA20). RSI neutral at 45. OFD pattern: =DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.88% (CS: 50) | Neutral |
| RSI_14 | 45.4 | Neutral |
| MACD Histogram | 0.37 | Bullish |
| vs SMA20 | 1.000x | Below |
| vs SMA50 | 0.968x | Below |
| vs SMA200 | 1.037x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $138.76
- **Stop Loss:** $134.50 (3.1% risk)
- **Target:** $143.02 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 193
- **Position Value:** $26,780.68
- **Portfolio %:** 26.78%
- **Risk Dollars:** $825.00
- **Risk Per Trade:** 0.83%
- **Modifiers:** L1 110% | L2 75% | Combined 0.83x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

**Next:** 2026-02-03 (Est: $1.41)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.23 | $1.37 | +11.1% |
| 2025Q2 | $1.15 | $1.26 | +9.9% |
| 2025Q1 | $0.95 | $1.03 | +8.0% |
| 2024Q4 | $1.13 | $1.18 | +4.9% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*